Mei Sheng Duh

Managing Principal

Expert

Mei Sheng Duh

Boston

Education

Sc.D., pharmacoepidemiology, Harvard School of Public Health; M.P.H., chronic disease epidemiology, Yale Medical School; B.S., pharmacy, Kaohsiung Medical College, Taiwan

Summary of Experience

Dr. Duh is a pharmacoepidemiologist specializing in the safety, health economics, and outcomes of pharmaceuticals and medical devices. She has published more than 110 articles in peer-reviewed journals in the areas of drug safety, health economics, outcomes research, patient reported outcomes, comparative effectiveness research, direct and indirect costs, and cost-effectiveness analysis, and has utilized data from clinical trials, literature, large health insurance claims databases, medical records review, patient surveys, and Medwatch spontaneous reports data. She has led research and publications for numerous pharmaceutical companies in the areas of health economics and outcomes research, the U.S. Food and Drug Administration's post-marketing commitment and post-marketing requirement studies, and the European Medicines Agency's post-authorization safety studies. Her work also includes pharmaceutical liability litigation and securities fraud litigation associated with adverse drug events that lead to product recall, market withdrawal, black box warnings, and FDA limited access programs.

Dr. Duh served as a chairperson for Drug Information Association annual meetings and was an adjunct assistant professor of pharmacoeconomics and pharmacoepidemiology at Massachusetts College of Pharmacy and Allied Health Sciences in Boston. She is a visiting scholar in the biostatistics department and a guest lecturer in the epidemiology department, both at the Harvard University School of Public Health. Dr. Duh was appointed to an expert panel convened by the Foundation for the National Institutes of Health's Observational Medical Outcomes Partnership (OMOP) to develop methodologies for studying drug-induced liver injuries on a national scale. She has served as a peer reviewer for several journals, including PharmacoEconomics, American Journal of Hospital-System Pharmacists, Chest, Pharmacoepidemiology and Drug Safety, American Journal of Kidney Diseases, and Therapeutics and Clinical Risk Management. Dr. Duh is also an elected member of the American Society of Hematology, and a member of the International Society of Pharmacoepidemiology and the International Society of Pharmacoeconomics and Outcomes Research.

View Dr. Duh's selected publications on the Harvard Catalyst website

Selected Publishing

  • The epidemiology of herpes zoster and its complications in Medicare cancer patients

    BMC Infect Dis. 2015 Feb 27;15(1):106. doi: 10.1186/s12879-015-0810-6
    2015

    Yenikomshian MA, Guignard AP, Haguinet F, LaCasce AS, Skarin AT, Trahey A, Karner P, Duh MS

      View article
    EpidemiologyHealth Care
  • Incremental direct and indirect costs of untreated vasomotor symptoms

    Menopause, August 25, 2014
    2014

    Sarrel P, Portman D, Lefebvre P, Lafeuille M, Grittner A, Fortier J, Gravel J, Duh MS, Aupperle P

      View abstract
    Health Care
  • Meta-Analysis of the Efficacy and Safety of Bortezomib Re-Treatment in Patients With Multiple Myeloma

    Clinical Lymphoma Myeloma and Leukemia, June 2014
    2014

    Knopf K, Duh MS, Lafeuille M, Gravel J, Lefebvre P, Niculescu L, Ba-Mancini A, Ma E, Shi H, Comenzo R

      View abstract
    Health Care
  • What Attorneys Should Know About FDA's MedWatch Data

    Law360, January 29, 2014
    2014

    Duh MS, Cremieux P, Greenberg P, Ellman B

      View article
    Health Care
  • Opportunities for Improving Attainment of Quality Measures in Patients With Type 2 Diabetes Mellitus

    American Journal of Managed Care, Volume 20, Number 1, Supplement - January 2014
    2014

    Bailey R, Blonde L, Damaraju CV, Duh MS, Garber L, Gravel J, Grittner A, Lafeuille M, Lefebvre P, Martin S, Meininger G, Rupnow M

      View article
    Health Care
  • Medicaid spending on contraceptive coverage and pregnancy-related care

    Reproductive Health, Mar 3, 2014, Volume 11, No. 1
    2014

    Laliberte F, Lefebvre P, Law A, Duh MS, Pocoski J, Lynen R, Darney P

      View abstract
    Health Care
  • Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes

    Applied Health Economics and Health Policy, April 2014, Vol. 12, No. 2
    2014

    Oglesby A, Korves C, Laliberte F, Dennis G, Rao S, Suthoff ED, Wei R, Duh MS

      View abstract
    Health Care
  • Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism

    The Patient, September 2013, Vol. 6, No. 3
    2013

    Laliberte F, Bookhart BK, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS

      View abstract
    Health Care
  • Evaluating the utility of existing patient-reported outcome scales in novel patient populations with pancreatic cancer, lung cancer, and myeloproliferative neoplasms using medicare current beneficiary survey data

    Patient. 2013; 6(3):189-200
    2013

    Ivanova JI, Mytelka DS, Duh MS, Birnbaum HG, Cummings AK, San Roman AM, Price GL, Swindle RW

      View abstract
    Health Care
  • All-cause and disease-related health care costs associated with recurrent venous thromboembolism

    Thrombosis and Haemostasis, December 2013, Vol. 110, No. 6
    2013

    Lefebvre P, Laliberte F, Nutescu EA, Duh MS, LaMori J, Bookhart BK, Olson WH, Dea K, Hossou Y, Schein J, Kaatz S

      View abstract
    Health Care
  • Costs Associated with Intravenous Cancer Therapy Administration in Patients with Metastatic Soft Tissue Sarcoma in a US Population

    Sarcoma. 2013;2013:947413
    2013

    Duh MS, Hackshaw MD, Ivanova JI, Kruse G, Miller LA, Lefebvre P, Karner P, Wong B

      View abstract
    Health Care
  • Direct and indirect cost burden associated with multiple sclerosis relapses: excess costs of persons with MS and their spouse caregivers

    Journal of the Neurological Sciences, July 2013, Vol. 330, No. 1-2
    2013

    Parisé H, Laliberte F, Lefebvre P, Duh MS, Kim E, Agashivala N, Abouzaid S, Weinstock-Guttman B

      View abstract
    Health Care
  • A single-center experience with low-dose warfarin in patients undergoing total hip or knee replacement surgery

    Current Orthopaedic Practice, May/June 2012 (Volume 23; Issue 3)
    2012

    Balcom W, Mishol D, Eapen S, Bookhart B, Nutescu E, Schein J, Duh MS 

      View abstract
    Health Care
  • All-Cause and Potentially Disease-Related Health Care Costs Associated with Venous Thromboembolism in Commercial, Medicare, and Medicaid Beneficiaries

    Journal of Managed Care Pharmacy (June 2012, Vol. 18, Issue 5)
    2012

    Lefebvre P, Laliberté F, Nutescu E, Duh MS, LaMori J, Bookhart B, Olson W, Dea K, Schein J, Kaatz S

      View abstract
    Health Care
  • Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy

    European Journal of Paediatric Neurology, September 2012, Vol. 16, No. 5
    2012

    Helmers SL, Duh MS, Guerin A, Sarda SP, Samuelson TM, Bunker MT, Olin BD, Jackson SD, Faught E

      View abstract
    Health Care
  • Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy

    Epilepsy Behav. 2011 Oct;22(2):370-5.
    2011

    Helmers S, Duh MS, Guerin A, Sarda S, Samuelson T, Bunker M, Olin B, Jackson S, Faught E

      View abstract
    Health Care
  • Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population

    J Med Econ. 2011;14(3):324-34.
    2011

    Vekeman F, LaMori J, Laliberte F, Nutescu E, Duh MS, Bookhart B, Schein J, Dea K, Olson W, Lefebvre P

      View abstract
    Health Care
  • Lifetime costs to Medicare of providing care to patients with chronic lymphocytic leukemia

    Leuk Lymphoma. 2011 Nov 23
    2011

    Lafeuille M, Vekeman F, Wang S, Kerrigan M, Menditto L, Duh MS

      View abstract
    Health Care
  • Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease

    J Clin Pharm Ther. 2011 May 18. doi: 10.1111/j.1365-2710.2011.01276.x
    2011

    Jordan L, Vekeman F, Sengupta A, Corral M, Guo A, Duh MS

      View abstract
    Health Care
  • Does the Route of Administration for Estrogen Hormone Therapy Impact the Risk of Venous Thromboembolism?

    Menopause. 2011 Oct;18(10):1052-9.
    2011

    Laliberte F, Dea K, Duh MS, Kahler K, Rolli M, Lefebvre P

      View article
    Health Care
  • Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costs

    2011 Mar;105(3):435-41. Epub 2010 Sep 29.
    2011

    Toy E, Beaulieu N, McHale J, Welland T, Plauschinat C, Swensen A, Duh MS

      View abstract
    Health Care
  • Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy

    BMC Cancer. 2011 Mar 24;11(1):105.
    2011

    Porta C, Paglino C, Imarisio I, Canipari C, Chen K, Neary M, Duh MS

      View abstract
    Health Care
  • Epidemiologic evaluation of cardiovascular risk in patients receiving milnacipran, venlafaxine, or amitriptyline: evidence from French health data

    Ann Pharmacother. 2011 Feb 8.
    2011

    Mease PJ, Zimetbaum PJ, Duh MS, Vekeman F, Guerin A, Boerstoel-Streefland M, Jiang W, Lefebvre P

      View abstract
    Health Care
  • Concomitant asthma medication use in patients receiving omalizumab: results from three large insurance claims databases

    J Asthma. 2011 Nov;48(9):923-30
    2011

    Lafeuille M, Duh MS, Zhang J, Wertz D, Gu T, Swensen A, Lefebvre P

      View abstract
    Health Care
  • Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from U.S. community oncology clinics

    Med Oncol. 2011 Apr 9.
    2011

    Feinberg B, Jolly P, Wang S, Fortner B, Scott J, Gilmore J, Neary M, Duh MS

      View abstract
    Health Care
  • Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial

    Eur J Cancer. 2011 Jun 18.
    2011

    Cella D, Pickard A, Duh MS, Guerin A, Mishagina N, Antras L, Neary M, McCann L, Hodge R, Sternberg CN

      View abstract
    Health Care
  • Mortality and Nonadherence to AEDS

    Sudden Unexpected Death in Epilepsy: Continuing the Global Conversation (Epilepsy Australia, Epilepsy Bereaved, and SUDEP Aware/North America, 2011)
    2011

    Duh MS, Greenberg PE, Guerin A, Korves C

    Health Care
  • Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil

    Drugs Aging. 2010; 27(11):903-913.
    2010

    Scharre D,  Vekeman FLefebvre P, Mody-Patel N, Kahlers K,  Duh M

      View abstract
    EpidemiologyHealth Care
  • Costs Associated with Angiogenesis Inhibitor Therapies for Metastatic Renal Cell Carcinoma in Clinical Practice: Results from A Medical Chart Review Study

    Urol Oncol. 2010 Oct 4
    2010

    Choueiri T, McDermott D,  Duh M, Antras L, Chen K, Sarda S, Luka A, Neary M, Oh W

      View abstract
    EpidemiologyHealth Care
  • Generic antiepileptic drugs and associated medical resource utilization in the United States

    Neurology 2010 74: 1566-1574
    2010

    Labiner D, Paradis P, Manjunath R, Duh MSLafeuille M, Latremouille-Viau D, Lefebvre P, Helmers S

      View article
    EpidemiologyHealth Care
  • Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma

    Urol Oncol. 2010 May 5
    2010

    Elfiky A, Cho D, McDermott D, Rosenberg J, Fortner B, Antras L, Chen K,  Duh M, Jayawant S, Oh W, Atkins M, Choueiri T

      View abstract
    EpidemiologyHealth Care
  • Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices

    Transfusion, 2010 Jan;50(1):190-9. Epub 2009 Aug 28
    2010

    Raptis A,  Duh M, Wang ST, Dial E, Fanourgiakis I, Paley C, Modey-Patel N, Corral M, Scott J

      View abstract
    EpidemiologyHealth Care
  • Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: a retrospective medical records review

    J Cancer Res Ther. 2010 Jan-Mar;6(1):31-5
    2010

    Weide R, Koppler H, Antras L, Smith M, Chang M, Green J, Wintfeld N, Neary M,  Duh M

      View abstract
    EpidemiologyHealth Care
  • The Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease and Exacerbation Definition: A Review

    COPD: Journal of Chronic Obstructive Pulmonary Disease (2010; 7(3):214-28)
    2010

    Toy E, Gallagher K, Stanley E, Swensen A, Duh MS

      View abstract
    Health Care
  • Risk of Hepatotoxicity-Related Hospitalizations Among Patients Treated With Opioid-Acetaminophen Combination Prescription Pain Medications

    Pain Med. 2010 Nov;11(11):1718-25
    2010

    Duh MSVekeman FKorves CLefebvre P, Dial E, Viau-Latremouille D,  Stangle BLafeuille MGreenberg P

      View abstract
    EpidemiologyHealth Care
  • Removal of Opioid-Acetaminophen Combination Prescription Pain Medications: Assessing the Evidence for Hepatotoxicity and Consequences of Removal

    Pain Medicine 2010 Mar;11(3):369-78; 379-81
    2010

    Michna E, Duh MSKorves C, Dahl J

      View article
    Health Care
  • Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin

    Curr Med Res Opin. 2010 Feb; 26(2):355-63
    2010

    Signorovitch JDuh M, Sengupta A, Gu A, Grant R, Raut M, Mody S, Schein J, Fisher A, Ng D

      View abstract
    EpidemiologyHealth Care
  • The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease

    Value Health. 2009; 12(1):34-9
    2009

    Gosselin A, Luo R, Lohoues H, Toy E, Lewis B, Crawley J, Duh MS

      View abstract
    Health Care
  • Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries

    Curr Med Res Opin. 2009; 25(7):1793-1805
    2009

    Paradis PE, Latremouille-Viau D, Moore Y, Mishagina N, Lafeuille MLefebvre P, Gaudig M, Duh MS

      View abstract
    Health Care
  • Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review

    BJU Int. 2009 Oct 26
    2009

    Choueiri T,  Duh M, Clement J, Brick A, Rogers M, Kwabi C, Shah K, Percy A, Antras L, Jayawant S, Chen K, Wang S, Luka A, Neary M, McDermott D, Oh W

      View abstract
    EpidemiologyHealth Care
  • Drug utilization and cost considerations of erythropoiesis-stimulating agents in oncology patients receiving chemotherapy

    J Med Econ. 2009; 12(1):1-8
    2009

    Vekeman F, McKenzie R, Bookhart B,  Laliberté FDuh M, Piech C,  Lefebvre P

      View abstract
    EpidemiologyHealth Care
  • Impact of limiting erythropoiesis-stimulating agent use for chemotherapy-induced anemia on the United States blood supply margin

    Transfusion. 2009; 49(5):895-902
    2009

    Vekeman F, Bookhart B, White J, McKenzie R,  Duh MS, Piech C,  Lefebvre P

      View abstract
    EpidemiologyHealth Care
  • An assessment of erythroid response to epoetin alfa as a single agent versus in combination with granulocyte- or granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach

    Cancer 2009; 115(4):706-715
    2009

    Mundle S,  Lefebvre PVekeman FDuh M, Rastogi R, Moyo V

      View abstract
    EpidemiologyHealth Care
  • The Risks and Costs of Multiple-Generic Substitution of Topiramate

    Neurology
    2009

    Duh M, Paradis P, Latremouille-Viau D,  Greenberg P

      View abstract
    EpidemiologyHealth Care
  • Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective

    J Manag Care Pharm. 2009; 15(4):312-322
    2009

    Laliberte F, Bookhart B,  Vekeman F, Corral M,  Duh MS, Bailey R, Piech CT,  Lefebvre P

      View white paper
    EpidemiologyHealth Care
  • Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review

    Support Care Cancer
    2009

    Diel IJ, Weide R, Köppler H, Antras L, Smith M, Green J, Wintfeld N, Neary M,  Duh M

      View abstract
    EpidemiologyHealth Care
  • Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study

    Epilepsia, 2009 Mar
    2009

    Faught RE, Weiner JR,  Guerin A, Cunnington MC,  Duh M

      View abstract
    EpidemiologyHealth Care
  • Impact of compliance with proton pump inhibitors on NSAID treatment

    Am J Manag Care
    2009

    Duh M, Gosselin A, Luo R, Lohoues H, Lewis BE, Crawley JA

      View abstract
    EpidemiologyHealth Care
  • The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence

    Expert Opin Pharmacother. 2009 Oct;10(14):2317-28. Review
    2009

    Duh M, Cahill K, Paradis P, Cremieux PGreenberg P

      View abstract
    Health Care
  • Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia

    Cancer. 2009; 115(20):4839-48
    2009

    Heaney M, Toy E,  Vekeman FLaliberte F, Dority B, Perlman D, Barghout V,  Duh M

      View abstract
    EpidemiologyHealth Care
  • Costs associated with cardiovascular events in patients with hypertension in U.S. managed care settings

    J Am Soc Hypertens. 2009 Nov-Dec; 3(6):403-15
    2009

    Duh M, Fulcher NM, White LA, Jayawant SS, Ramamurthy P, Moyneur E, Ong SH

      View abstract
    EpidemiologyHealth Care
  • Economic Impact of Generic Substitution of Lamotrigine: Projected Costs in the United States Using Findings in a Canadian Setting

    Current Medical Research and Opinion 2008 Apr;24(4):1069-81
    2008

    LeLorier J, Duh MS, Paradis PE, Latremouille-Viau D, Lefebvre P, Manjunath R, Sheehy O

      View abstract
    Health Care
  • The Economic Impact of Pre-Dialysis Epoetin Alfa on Health Care and Work Loss Costs in Chronic Kidney Disease: An Employer's Perspective

    Disease Management 2008 Feb;11(1):49-58
    2008

    Moyneur E, Bookhart BK, Mody SH, Fournier AA, Mallett D, Duh MS

      View abstract
    Health Care
  • The impact of psoriasis on health care costs and patient work loss

    Journal of the American Academy of Dermatology, November 2008
    2008

    Fowler J, Duh M, Rovba L, Buteau S, Pinheiro L, Lobo F, Sung J, Doyle J, Swensen A, Mallett D, Kosicki G

      View abstract
    EpidemiologyHealth Care
  • Clinical Consequences of Generic Substitution of Lamotrigine for Patients with Epilepsy

    Neurology 2008 May 27;70(22 Pt 2):2179-86
    2008

    LeLorier J,  Duh M, Paradis PE,  Lefebvre P, Weiner J, Manjunath R, Sheehy O

      View abstract
    EpidemiologyHealth Care
  • Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis.

    Ann Hematol 2008; 87(7):527-536
    2008

    Moyo V, Lefebvre P, Duh MS, Yektashenas B, Mundle S

      View abstract
    EpidemiologyHealth Care
  • Management of anaemia: a critical and systematic review of the cost effectiveness of erythropoiesis-stimulating agents.

    PharmacoEconomics 2008;26(2):99-120.
    2008

    Duh MS, Weiner JR, White LA, Lefebvre P, Greenberg PE

      View abstract
    Health Care
  • Symptom assessment in relapsed small cell lung cancer: cross-validation of the patient symptom assessment in lung cancer instrument.

    Journal of Thoracic Oncology 2008 Oct;3(10):1137-45
    2008

    Chen L, Antras L, Duh M, Neary MP, O'Brien ME

      View abstract
    EpidemiologyHealth Care
  • Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature

    Expert Opinion on Pharmacotherapy
    2008

    Weiner J, Toy E, Sacco P, Duh M

      View abstract
    EpidemiologyHealth Care
  • Costs Associated with Intravenous Chemotherapy Administration in Patients with Small Cell Lung Cancer: A Retrospective Claims Database Analysis

    Curr Med Res Opin 2008;24(4):967-974
    2008

    Duh M, Reynolds Weiner J, Lefebvre P, Neary M, Skarin AT

      View abstract
    Health Care
  • Cost Analytic Model to Determine the Least Costly Inpatient Erythropoiesis Stimulating Therapy Regimen

    The Annals of Pharmacotherapy 2008 Jan;42(1):16-23.
    2008

    Sikand H, Greco T, Watson SH, Mody SH, Piech CT, Kang YJ, Decter A, Duh MS, Naeem A

      View abstract
    Health Care
  • Anaemia and the risk of injurious falls in a community-dwelling elderly population.

    Drugs Aging 2008;25(4):325-34.
    2008

    Duh M, Mody SH, Lefebvre P, Woodman RC, Buteau S, Piech CT

      View abstract
    EpidemiologyHealth Care
  • Drug Safety and Risk Management Practice: What Drug Companies Can Do

    FDLI Update 2008, Issue 3. With Permission from FDLI
    2008

    Duh MS, Greenberg P, Antras L

      View article
    EpidemiologyHealth Care
  • Anemia and the risk of injurious falls in a community-dwelling elderly population

    Drugs Aging. 2008; 25(4):325-34
    2008

    Duh MS, Mody SH,  Lefebvre P, Woodman RC, Buteau S, Piech CT

      View abstract
    EpidemiologyHealth Care
  • The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid

    Cancer 2007 Mar;109(6):1090-6
    2007

    Oh W, Proctor K, Nakabayashi M, Evan C, Tormey L, Daskivich T, Antras L, Smith M, Neary M, Duh M

      View abstract
    EpidemiologyHealth Care
  • Health Care Costs of Adults Treated for Attention-Deficit, Hyperactivity Disorder Who Received Alternative Drug Therapies

    J Manag Care Pharm 2007 Sep;13(7):561-9
    2007

    Wu E, Birnbaum H, Zhang H, Ivanova J, Yang E, Mallet D

      View abstract
    Health Care
  • Is There a Difference in the Cost-Effectiveness of Erythropoietic Therapies for the Treatment of Anemia in Patients Receiving HCV Combination Therapy?

    Hepatology. 2007 Jul;46(1):283 [Letter to the Editor]
    2007

    Wu WK, Duh M, Lefebvre P

      View abstract
    Health Care
  • The Role of Epidemiology in Drug Safety Litigations

    FDLI Update 2007, Issue 6. With Permission from FDLI
    2007

    Duh M, Greenberg P, Weiner J

      View article
    EpidemiologyHealth Care
  • Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes

    Epilepsia 2007 Mar;48(3):464-9
    2007

    Andermann F, Duh M, Gosselin A, Paradis P

    EpidemiologyHealth Care
  • The Economic Impact of Epoetin Alfa Therapy on Delaying Time to Dialysis in Elderly Patients with Chronic Kidney Disease

    Disease Management 2007 Feb; 10(1):37-45.
    2007

    Lefebvre P, Duh MS, Mody SH, Bookhart BK, Piech CT

      View abstract
    EpidemiologyHealth Care
  • Drug Utilization and Costs of Erythropoietic-Stimulating Agents in Chronic Kidney Disease Patients Not Receiving Dialysis

    Managed Care Interface 2007; Dec:14-19
    2007

    Duh MS, Mody SH, Laliberte F, McKenzie RS, Bookhart B, Lefebvre P

    Health Care
  • Medical and work loss burden of pre-dialysis chronic kidney disease and related anemia: an employer's perspective

    Journal of Health & Productivity 2007 (Oct): 3-9
    2007

    Moyneur E, Bookhart B, Mody SH, Fournier A, Mallet D, Duh MS

    EpidemiologyHealth Care
  • The Direct and Indirect Cost Burden of Atopic Dermatitis: An Employer-Payer Perspective

    Managed Care Interface, October 2007
    2007

    Fowler J, Duh M, Rovba L, Buteau S, Pinheiro L, Lobo F, Sung J, Doyle J, Swensen A, Mallett D, Kosicki G

      View article
    Health Care
  • Dose and cost comparison of erythropoietic agents in the inpatient hospital setting

    American Journal of Health-System Pharmacy, September 15, 2007;64(18):1943-9
    2007

    McKenzie RS, Mody SH, Piech CT, Watson SH, Duh MS, Lefebvre P, Vekeman F

      View abstract
    Health Care
  • The Economic Consequences of Generic Substitution for Antiepileptic Drugs in a Public Payer Setting: The Case of Lamotrigine

    Disease Management
    2007

    Duh MS, Andermann F, Paradis PE, Weiner J, Manjunath R, Cremieux P

      View abstract
    Health Care
  • Psychometric validation of the Patient Symptom Assessment in Lung Cancer instrument for small cell lung cancer

    Current Medical Research Opinion, 2007;23(11):2741-52
    2007

    Levy N, Neary M, O'Brien M, von Pawel J, Antras L, Chen L, Duh M

      View abstract
    EpidemiologyHealth Care
  • Red blood cell transfusions and the risk of ARDS among critically ill: a cohort study

    Crit Care 2007 Jun 6; 11 (3): R63
    2007

    Zilberberg M, Carter C, Lefebvre P, Raut M, Vekeman F, Duh M, Shorr A

      View abstract
    EpidemiologyHealth Care
  • Impact and Treatment of Anemia in the Elderly: Clinical, Epidemiological, and Economic Perspectives

    Expert Review of Pharmacoeconomics & Outcomes Research
    2006

    Duh M, Latypova A, Greenberg P

      View abstract
    EpidemiologyHealth Care
  • Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer

    J Urol 2006 Jan;175(1):136-9
    2006

    Boyce S, Brandman J, Duh M, Moyneur E, Raut M, Smith M

      View abstract
    EpidemiologyHealth Care
  • Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs.

    J Am Acad Dermatol 2006 Mar; 54(3):448-57.
    2006

    Fowler JF, Ghosh A, Sung J, Emani S, Chang J, Den E, Thorn D, Person J, Duh M

      View abstract
    EpidemiologyHealth Care
  • Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations

    Curr Med Res Opin. 2006 Jul; 22(9): 1623-31
    2006

    Lefebvre P, Gosselin A, McKenzie RS, Mody SH, Piech CT, Duh MS

      View abstract
    Health Care
  • Dosing Patterns and Costs of Erythropoietic Agents in Patients with Chronic Kidney Disease Not on Dialysis in Managed Care Organizations

    Clin Ther 2006 Sep;28(9):1443-50
    2006

    Duh M, Mody S, McKenzie RS, Lefebvre P, Gosselin A, Tak Piech C

      View abstract
    Health Care
  • Dosing Patterns and Treatment Costs of Erythropoietic Agents in Elderly Patients with Pre-Dialysis Chronic Kidney Disease in Managed Care Organisations

    Drugs Aging 2006;23(12):969-76
    2006

    Duh M, Mody S, McKenzie S, Lefebvre P, Gosselin A, Bookhard B, Piech C

      View abstract
    Health Care
  • Benefits Associated with an Early Hemoglobin Response to Epoetin Alfa Therapy in the Treatment of Chemotherapy-Related Anemia

    J Natl Compr Canc Netw 2005 Nov;3(6):807-16
    2006

    Campos S, Duh M, Lefebvre P, Rosberg J

      View abstract
    EpidemiologyHealth Care
  • Alkaline phosphatase predicts survival in patients with metastatic neuroendocrine tumors

    Dig Dis Sci 2006 May;51(5):877-84
    2006

    Clancy T, Sengupta T, Paulus J, Ahmed F, Duh M, Kulke M

      View abstract
    EpidemiologyHealth Care
  • Algorithms to identify colonic ischemia, complications of constipation and irritable bowel syndrome in medical claims data: development and validation

    Pharmacoepidemiol Drug Saf 2006 Jan;15(1):47-56
    2006

    Sands B, Duh M, Cali C, Ajene A, Bohn R, Miller D, Cole J, Cook S, Walker A

      View abstract
    EpidemiologyHealth Care
  • Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors

    Clinical Breast Cancer 2006 Jun;7(2):127-32
    2006

    Mincey B, Duh M, Thomas S, Moyneur E, Marynchenko M, Boyce S, Mallett D, Perez E

      View abstract
    EpidemiologyHealth Care
  • Medical Costs of Untreated Anemia in Elderly Patients with Predialysis Chronic Kidney Disease

    J Am Soc Nephrol 2006 Dec;17(12):3497-502
    2006

    Lefebvre P, Duh M, Buteau S, Bookhart B, Mody S

      View abstract
    Health Care
  • A survey-based assessment of the prevalence and severity of chronic hand dermatitis in a managed care organization

    Cutis. 2006 Jun; 77(6):385-92.
    2006

    Fowler J, Duh MS, Chang J, Person J, Thorn D, Raut M, Ghosh A, Den E, Reynolds J

      View abstract
    EpidemiologyHealth Care
  • Computerized algorithms for the identification of irritable bowel syndrome, colonic ischemia, and complications of constipation

    Pharmacoepidemiol Drug Saf. 2006 Jan;15(1):47-56
    2006

    Sands BE, Duh MS, Cali C, Ajene A, Bohn RL, Miller D, Cole JA, Cook SF, Walker AM

      View abstract
    EpidemiologyHealth Care
  • Assessing the risk of clinical fracture in men with non-metastatic prostate cancer receiving gonadotropin-releasing hormone agonist therapy

    J of Urology 2006 Jan; 175(1):136-9; discussion 139
    2006

    Smith M, Boyce S, Moyneur E, Duh MS, Raut M, Brandman J

    EpidemiologyHealth Care
  • Assessing the Clinical Benefits of Erythropoietic Agents Using Area Under the Hemoglobin Change Curve

    Oncologist. 2005 Jun-Jul;10(6):438-48
    2005

    Duh MSLefebvre P, Fastenau J, Piech C, Waltzman R

      View abstract
    Health Care
  • The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia

    Curr Med Res Opin. 2005 Oct;21(10):1677-82.
    2005

    Ben-Hamadi R, Duh MS, Aggarwal J, Henckler A, McKenzie RS, Tak Piech C

      View abstract
    Health Care
  • Cost-effectiveness of epoetin alfa and darbepoetin alfa in patients with chemotherapy-related anemia

    Expert Rev Pharmacoecon Outcomes Res. 2005 Aug;5(4):383-94. doi: 10.1586/14737167.5.4.383.
    2005

    Duh M, L Mark T

      View abstract
    Health Care
  • Red Blood Cell Transfusion and Ventilator-Associated Pneumonia: A Potential Link?

    Crit Care Med. 2004 Mar;32(3):666-74.
    2004

    Shorr A, Duh M, Kelly K, Kollef M

      View abstract
    Health Care
  • The CRIT Study: Anemia and blood transfusion in the critically ill – current clinical practice in the United States

    Crit Care Med 2004 Jan;32(1):39-52
    2004

    Corwin H1, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ

      View abstract
    Health Care
  • Lack of Intraocular Pressure Effect of Budesonide Inhalation Therapy in a Mixed Asthmatic Population

    Annals of Asthma, Allergy & Immunology 2000;85: 356-61
    2000

    Duh M, Walker A, Lindmark B, Laties A

    EpidemiologyHealth Care
  • Descriptive epidemiology of acute liver enzyme abnormalities in the general population of central Massachusetts

    Pharmacoepidemiol Drug Saf 1999 Jul;8(4):275-83
    1999

    Duh M, Walker A, Kronlund K Jr

      View abstract
    EpidemiologyHealth Care
  • Interpretation of the Weight Matrix in an Artificial Neural Network

    American Journal of Epidemiology 1998; 147: 1112-1122.
    1998

    Duh MS, Walker AM, Ayanian JZ

    Health Care
  • Epidemiologic interpretation of artificial neural networks

    Am J Epidemiol 1998 Jun 15;147(12):1112-22
    1998

    Duh M, Walker A, Ayanian J

      View white paper
    EpidemiologyHealth Care
  • Prediction and cross-validation of neural networks versus logistic regression: using hepatic disorders as an example

    Am J Epidemiol 1998 Feb 15;147(4):407-13
    1998

    Duh M, Walker A, Pagano M, Kronlund K

      View abstract
    EpidemiologyHealth Care
  • Prediction and cross-validation in modeling incident cases of hepatic disorders using automated medical data

    American Journal of Epidemiology 1998; 147:407-13
    1998

    Duh M, Walker A, Pagano M, Kronlund K

      View abstract
    EpidemiologyHealth Care
  • The Effectiveness of Surgery on the Treatment of Acute Spinal Cord Injury and Its Relationship with Pharmacological Treatment

    Neurosurgery
    1994

    Duh M, Shepard MJ, Wilberger JE, Bracken MB

      View abstract
    EpidemiologyHealth Care
  • The effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment

    Neurosurgery 1994 Aug;35(2):240-8; discussion 248-9
    1994

    Duh M, Shepard M, Wilberger J, Bracken M

      View abstract
    EpidemiologyHealth Care
Mei Sheng Duh
Expertise
Additional Practices